Literature DB >> 19160385

Cochlear implantation is associated with minimal anesthetic risk in the elderly.

Daniel H Coelho1, Joseph Yeh, Jung T Kim, Anil K Lalwani.   

Abstract

OBJECTIVES/HYPOTHESIS: Most elderly patients with severe to profound hearing loss are not being referred for cochlear implantation (CI), the only intervention to significantly improve hearing and quality of life in this population. Possible concern over the risks of anesthetic in the elderly may be one of the foremost concerns. The authors investigated whether advanced age is a risk factor when undergoing general anesthesia for cochlear implantation. STUDY
DESIGN: Retrospective chart review.
METHODS: A retrospective chart review was conducted at a tertiary academic referral center of 70 patients older than 70 years, who underwent CI with general anesthesia between 1984 and 2007, and for whom anesthesia records were available. Patients were divided into anesthetic risk group A (American Society of Anesthesiologist classification [ASA] I/II) and B (ASA III/IV). Intraoperative and postoperative anesthesia-related complications were identified.
RESULTS: Of the 70 patients, 44 were in group A and 26 were in group B, both with a mean age of 77. Four patients, one from group A and three from group B, required intraoperative pressors for blood pressure support. There were no anesthesia-related complications in group A, but there were three (12% of group B and 4% overall) in group B: delayed extubation, postoperative congestive heart failure, and urinary retention. There was no long-term morbidity or mortality.
CONCLUSIONS: General anesthesia is well tolerated by elderly patients undergoing cochlear implantation. Preexisting medical condition of the patient as defined by ASA is a better predictor of intraoperative and postoperative complication than age alone.

Entities:  

Mesh:

Year:  2009        PMID: 19160385     DOI: 10.1002/lary.20067

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  Cochlear implant rehabilitation in older adults: literature review and proposal of a conceptual framework.

Authors:  James H Clark; Jennifer Yeagle; Alicia I Arbaje; Frank R Lin; John K Niparko; Howard W Francis
Journal:  J Am Geriatr Soc       Date:  2012-09-13       Impact factor: 5.562

2.  Postoperative cognitive dysfunction after cochlear implantation.

Authors:  Annes J Claes; Suzanne de Backer; Paul Van de Heyning; Annick Gilles; Vincent Van Rompaey; Griet Mertens
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-18       Impact factor: 2.503

3.  [Cochlear implant device failure after cardioversion].

Authors:  C Schild; R Beck; C C Boedeker; T Wesarg; S Arndt; A Aschendorff; R Laszig
Journal:  HNO       Date:  2011-05       Impact factor: 1.284

4.  Modeling Hearing Loss Progression and Asymmetry in the Older Old: A National Population-Based Study.

Authors:  Rahul K Sharma; Anil K Lalwani; Justin S Golub
Journal:  Laryngoscope       Date:  2020-11-08       Impact factor: 3.325

5.  Qualitative, multimethod study of behavioural and attitudinal responses to cochlear implantation from the patient and healthcare professional perspective in Australia and the UK: study protocol.

Authors:  Frances Rapport; Mia Bierbaum; Catherine McMahon; Isabelle Boisvert; Annie Lau; Jeffrey Braithwaite; Sarah Hughes
Journal:  BMJ Open       Date:  2018-05-29       Impact factor: 2.692

Review 6.  Mythbusters! The Truth about Common Misconceptions in Cochlear Implantation.

Authors:  Erika A Woodson; Ksenia Aaron; Ahn Nguyen-Huynh; Jonathan Vargo; Sarah E Mowry
Journal:  Semin Hear       Date:  2021-12-09

Review 7.  Safety and outcomes of cochlear implantation in the elderly: A review of recent literature.

Authors:  Zao Yang; Maura Cosetti
Journal:  J Otol       Date:  2016-04-02

8.  Exploring the recruitment, ethical considerations, conduct and information dissemination of an audiology trial: a pretrial qualitative study (q-COACH).

Authors:  Emilie Francis-Auton; Chris Warren; Jeffrey Braithwaite; Frances Rapport
Journal:  Trials       Date:  2020-01-06       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.